Clinical implication of CD166 expression in gastric cancer.

@article{Ishigami2011ClinicalIO,
  title={Clinical implication of CD166 expression in gastric cancer.},
  author={Sumiya Ishigami and Shinichi Ueno and Takaaki Arigami and Hideo Arima and Yasuto Uchikado and Yoshiaki Kita and Ken Sasaki and Yuka Nishizono and Itaru Omoto and Hiroshi Kurahara and Masataka Matsumoto and Yuko Kijima and Shoji Natsugoe},
  journal={Journal of surgical oncology},
  year={2011},
  volume={103 1},
  pages={57-61}
}
BACKGROUND CD166 is one of the cell-surface immunoglobulins, and is well known to regulate leukocyte mobility. Its expression is associated with aggressive tumor behavior. CD166 expression is a prognostic marker in several cancers, but the predictive value of CD166 expression in gastric cancer has not been clarified yet. PATIENTS AND METHODS A total of 142 gastric cancer patients who consecutively received curative gastrectomy in Kagoshima University Hospital were enrolled in the current… CONTINUE READING
Highly Cited
This paper has 27 citations. REVIEW CITATIONS
10 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

Similar Papers

Loading similar papers…